Literature DB >> 30431139

Exosomes derived from PM2.5‑treated lung cancer cells promote the growth of lung cancer via the Wnt3a/β‑catenin pathway.

Hui Xu1, Xingai Jiao1, Yilei Wu2, Shuo Li1, Lili Cao1, Liang Dong1.   

Abstract

Fine particulate matter (PM2.5) is associated with an increased lung cancer risk. However, the effect of PM2.5 exposure on lung cancer cells is still largely unknown. The present study revealed that A549 lung cancer cells secreted exosomes containing high levels of Wnt3a after treatment with PM2.5. These exosomes activated β‑catenin signalling in A549 cells. These exosomes exhibited no effects on migration and invasion, but promoted proliferation of A549 cells via the Wnt3a/β‑catenin pathway in vitro. These exosomes promoted A549 tumour progression in a Wnt3a‑dependent fashion in vivo. These results demonstrated that PM2.5 has a direct effect on promoting lung tumour development. Inhibition of exosome production by tumour cells or blockade of the Wnt3a/β‑catenin pathway represents a promising strategy to impede PM2.5‑mediated lung tumour progression.

Entities:  

Year:  2018        PMID: 30431139     DOI: 10.3892/or.2018.6862

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  12 in total

Review 1.  Emerging role of exosomes in cancer progression and tumor microenvironment remodeling.

Authors:  Mahshid Deldar Abad Paskeh; Maliheh Entezari; Sepideh Mirzaei; Amirhossein Zabolian; Hossein Saleki; Mohamad Javad Naghdi; Sina Sabet; Mohammad Amin Khoshbakht; Mehrdad Hashemi; Kiavash Hushmandi; Gautam Sethi; Ali Zarrabi; Alan Prem Kumar; Shing Cheng Tan; Marios Papadakis; Athanasios Alexiou; Md Asiful Islam; Ebrahim Mostafavi; Milad Ashrafizadeh
Journal:  J Hematol Oncol       Date:  2022-06-28       Impact factor: 23.168

Review 2.  Environmental Exposures and Extracellular Vesicles: Indicators of Systemic Effects and Human Disease.

Authors:  Christina M Eckhardt; Andrea A Baccarelli; Haotian Wu
Journal:  Curr Environ Health Rep       Date:  2022-04-21

Review 3.  Generation, purification and engineering of extracellular vesicles and their biomedical applications.

Authors:  Jin Gao; Xinyue Dong; Zhenjia Wang
Journal:  Methods       Date:  2019-11-30       Impact factor: 3.608

Review 4.  Deciphering the Code between Air Pollution and Disease: The Effect of Particulate Matter on Cancer Hallmarks.

Authors:  Miguel Santibáñez-Andrade; Yolanda I Chirino; Imelda González-Ramírez; Yesennia Sánchez-Pérez; Claudia M García-Cuellar
Journal:  Int J Mol Sci       Date:  2019-12-24       Impact factor: 5.923

Review 5.  PM2.5, Fine Particulate Matter: A Novel Player in the Epithelial-Mesenchymal Transition?

Authors:  Zihan Xu; Wenjun Ding; Xiaobei Deng
Journal:  Front Physiol       Date:  2019-11-29       Impact factor: 4.566

Review 6.  Exosomes as Actively Targeted Nanocarriers for Cancer Therapy.

Authors:  Yan Wang; Yingru Zhang; Gang Cai; Qi Li
Journal:  Int J Nanomedicine       Date:  2020-06-17

7.  Extracellular vesicular Wnt7b mediates HPV E6-induced cervical cancer angiogenesis by activating the β-catenin signaling pathway.

Authors:  Jun-Jun Qiu; Shu-Gen Sun; Xiao-Yan Tang; Ying-Ying Lin; Ke-Qin Hua
Journal:  J Exp Clin Cancer Res       Date:  2020-11-25

Review 8.  Tumor-associated exosomes promote lung cancer metastasis through multiple mechanisms.

Authors:  Chunyang Jiang; Na Zhang; Xiaoli Hu; Hongyan Wang
Journal:  Mol Cancer       Date:  2021-09-13       Impact factor: 27.401

9.  Identification of Novel Lung Cancer Driver Genes Connecting Different Omics Levels With a Heat Diffusion Algorithm.

Authors:  Fei Yuan; Xiaoyu Cao; Yu-Hang Zhang; Lei Chen; Tao Huang; ZhanDong Li; Yu-Dong Cai
Journal:  Front Cell Dev Biol       Date:  2022-01-26

10.  MiR-185-5p targets RAB35 gene to regulate tumor cell-derived exosomes-mediated proliferation, migration and invasion of non-small cell lung cancer cells.

Authors:  Hongqing Wen; Zhiyan Liu; Jingjing Tang; Lina Bu
Journal:  Aging (Albany NY)       Date:  2021-09-09       Impact factor: 5.682

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.